{"id":"W3090684381","doi":"10.1007/s40265-020-01411-y","title":"Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Pertuzumab; Lapatinib; Medicine; Biosimilar; Neratinib; Trastuzumab emtansine; Metastatic breast cancer; Breast cancer; Oncology; Targeted therapy; Internal medicine; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406512,0.0007728872,0.00165207,0.00150232,0.0001373364,0.001158471,0.0008190161,0.001384265,0.00467519],"category_scores_gemma":[0.001624999,0.0002206383,0.0009274295,0.001457749,0.0004167004,0.001638886,0.0007108465,0.002569919,0.001461389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007067514,"about_ca_system_score_gemma":0.00111502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008534599,"about_ca_topic_score_gemma":0.001919593,"domain_scores_codex":[0.999627,0.00009175191,0.00004539537,0.00005787189,0.0001376309,0.00004028017],"domain_scores_gemma":[0.9992055,0.0005084726,0.00009408622,0.00001440665,0.0001318319,0.00004569049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001910927,0.00006713384,0.00008934835,0.01769165,0.0001389281,0.0001240615,0.0000323468,0.000442086,0.001579189,0.005763621,0.02713766,0.9467428],"study_design_scores_gemma":[0.0001140238,0.0002203701,0.0005154674,0.006248644,0.0002874481,0.0006603362,0.000039463,0.0002089233,0.0005005923,0.003329387,0.9878532,0.00002226939],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000935069,0.9984402,0.0001613694,0.000472812,0.000219082,0.000004492862,0.00002193436,0.000006430703,0.0005802317],"genre_scores_gemma":[0.0006873891,0.9978945,0.0002287156,0.0005907047,0.0002035378,0.000006019065,0.00003789957,0.000002217382,0.0003490105],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00467519,"threshold_uncertainty_score":0.01564002,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05352402178422109,"score_gpt":0.3772090738336325,"score_spread":0.3236850520494114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}